Suppr超能文献

有哮喘和过敏儿童的家庭中 SARS-CoV-2 感染和传播的危险因素:一项前瞻性监测研究。

Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study.

机构信息

Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo; Department of Pediatrics, National Jewish Health, Denver, Colo; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, Colo.

Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo; Department of Biomedical Research, National Jewish Health, Denver, Colo; Department of Biostatistics and Informatics, University of Colorado, Denver, Colo.

出版信息

J Allergy Clin Immunol. 2022 Aug;150(2):302-311. doi: 10.1016/j.jaci.2022.05.014. Epub 2022 Jun 1.

Abstract

BACKGROUND

Whether children and people with asthma and allergic diseases are at increased risk for severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection is unknown.

OBJECTIVE

Our aims were to determine the incidence of SARS-CoV-2 infection in households with children and to also determine whether self-reported asthma and/or other allergic diseases are associated with infection and household transmission.

METHODS

For 6 months, biweekly nasal swabs and weekly surveys were conducted within 1394 households (N = 4142 participants) to identify incident SARS-CoV-2 infections from May 2020 to February 2021, which was the pandemic period largely before a vaccine and before the emergence of SARS-CoV-2 variants. Participant and household infection and household transmission probabilities were calculated by using time-to-event analyses, and factors associated with infection and transmission risk were determined by using regression analyses.

RESULTS

In all, 147 households (261 participants) tested positive for SARS-CoV-2. The household SARS-CoV-2 infection probability was 25.8%; the participant infection probability was similar for children (14.0% [95% CI = 8.0%-19.6%]), teenagers (12.1% [95% CI = 8.2%-15.9%]), and adults (14.0% [95% CI = 9.5%-18.4%]). Infections were symptomatic in 24.5% of children, 41.2% of teenagers, and 62.5% of adults. Self-reported doctor-diagnosed asthma was not a risk factor for infection (adjusted hazard ratio [aHR] = 1.04 [95% CI = 0.73-1.46]), nor was upper respiratory allergy or eczema. Self-reported doctor-diagnosed food allergy was associated with lower infection risk (aHR = 0.50 [95% CI = 0.32-0.81]); higher body mass index was associated with increased infection risk (aHR per 10-point increase = 1.09 [95% CI = 1.03-1.15]). The household secondary attack rate was 57.7%. Asthma was not associated with household transmission, but transmission was lower in households with food allergy (adjusted odds ratio = 0.43 [95% CI = 0.19-0.96]; P = .04).

CONCLUSION

Asthma does not increase the risk of SARS-CoV-2 infection. Food allergy is associated with lower infection risk, whereas body mass index is associated with increased infection risk. Understanding how these factors modify infection risk may offer new avenues for preventing infection.

摘要

背景

儿童和哮喘及过敏性疾病患者是否更容易感染严重急性呼吸综合征病毒 2(SARS-CoV-2)尚不清楚。

目的

本研究旨在确定儿童家庭中 SARS-CoV-2 感染的发生率,并确定自我报告的哮喘和/或其他过敏性疾病是否与感染和家庭传播有关。

方法

在 2020 年 5 月至 2021 年 2 月的 6 个月期间,在 1394 个家庭(4142 名参与者)中进行了每两周一次的鼻拭子和每周一次的调查,以确定 SARS-CoV-2 的感染情况。该研究时间主要处于大流行时期,疫苗尚未普及,SARS-CoV-2 变异株也尚未出现。使用时间事件分析计算参与者和家庭的感染和家庭传播概率,并通过回归分析确定与感染和传播风险相关的因素。

结果

共有 147 个家庭(261 名参与者)的 SARS-CoV-2 检测呈阳性。家庭 SARS-CoV-2 感染概率为 25.8%;儿童(14.0%[95%CI=8.0%-19.6%])、青少年(12.1%[95%CI=8.2%-15.9%])和成人(14.0%[95%CI=9.5%-18.4%])的参与者感染概率相似。感染症状在 24.5%的儿童、41.2%的青少年和 62.5%的成年人中出现。自我报告的医生诊断哮喘不是感染的危险因素(调整后的危险比[aHR]=1.04[95%CI=0.73-1.46]),上呼吸道过敏或湿疹也不是。自我报告的医生诊断的食物过敏与较低的感染风险相关(aHR=0.50[95%CI=0.32-0.81]);体重指数每增加 10 分,感染风险增加(aHR 每增加 10 点=1.09[95%CI=1.03-1.15])。家庭二次攻击率为 57.7%。哮喘与家庭传播无关,但食物过敏家庭的传播率较低(调整后的优势比[aOR]=0.43[95%CI=0.19-0.96];P=0.04)。

结论

哮喘不会增加 SARS-CoV-2 感染的风险。食物过敏与较低的感染风险相关,而体重指数与较高的感染风险相关。了解这些因素如何改变感染风险,可能为预防感染提供新的途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d609/9155183/76df565db632/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验